Realfiction (REALFI) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
28 Jul, 2025Executive summary
Revenue declined 55% year-over-year in Q2-2025 to TSEK 1,132, reflecting a strategic shift toward DPT commercialization.
Gross profit margin improved to 65.4% in Q2-2025 from 60.2% in Q2-2024 due to a different sales mix and lower sales prices.
Operating loss narrowed to TSEK -6,589 in Q2-2025 from TSEK -7,436 in Q2-2024, driven by reduced external and personnel costs.
Positive cash flow contribution continued from legacy mixed reality displays, despite expected revenue decline.
Major milestone achieved with the unveiling of the world's first MicroLED-based 3D display powered by DPT.
Financial highlights
Q2-2025 revenue: TSEK 1,132 (Q2-2024: TSEK 2,508); H1-2025 revenue: TSEK 2,006 (H1-2024: TSEK 4,211).
Q2-2025 gross profit: TSEK 740 (Q2-2024: TSEK 1,511); gross margin: 65.4% (Q2-2024: 60.2%).
Q2-2025 result after financial items: TSEK -7,662 (Q2-2024: TSEK -8,508); EPS: SEK -0.38 (Q2-2024: -0.43).
Cash flow from operating activities improved to TSEK -4,208 in Q2-2025 from TSEK -6,122 in Q2-2024.
Equity at 30 June 2025: TSEK 33,822 (Q2-2024: TSEK 52,309).
Outlook and guidance
Targeting NRE and up-front payments from multiple customer projects in 2025 and 2026, with per-unit license fees expected from late 2026 or early 2027.
Rights issue and loan refinancing expected to provide funding needed to commercialize DPT and reach operational cash-flow positivity.
Ongoing commercial discussions in automotive displays, LED walls, and with major display industry players.
Latest events from Realfiction
- Sharp revenue drop in Q3 as DPT sales paused; capital raised to support DPT commercialization.REALFI
Q3 202527 Nov 2025 - SEK 50 million rights issue supports commercialization of advanced glasses-free 3D display tech.REALFI
Status Update23 Nov 2025 - Q3-2024 saw record DPT-driven revenue growth and strong gross margins, with liquidity secured.REALFI
Q3 202413 Jun 2025 - Q2-2024 saw strong revenue growth and DPT licensing talks nearing a breakthrough.REALFI
Q2 202413 Jun 2025 - DPT commercialization accelerates with new funding and industry milestones despite lower revenue.REALFI
Q1 20256 Jun 2025 - Revenue surged and DPT commercialization advanced with a pivotal license agreement.REALFI
Q4 20245 Jun 2025